<DOC>
	<DOCNO>NCT00189735</DOCNO>
	<brief_summary>A dose finding study evaluate safety effectiveness FK778 kidney transplant patient</brief_summary>
	<brief_title>A Study Evaluate FK778 Kidney Transplant Patients</brief_title>
	<detailed_description />
	<criteria>Patient end stage kidney disease need retransplantation ( loss graft nonimmunological reason ) . Patient fully inform . Patient immunological high risk and/or previous graft survival shorter 1 year due immunological reason . Patient significant liver disease . Cold ischemia time donor kidney &gt; 28 hour . Patient uncontrolled concomitant infection and/or severe diarrhoea , vomit , active upper gastrointestinal tract malabsorption active peptic ulcer . Patient previously receive receive organ transplant kidney .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Anti-rejection therapy</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Antirejection</keyword>
	<keyword>Malononitrilamide</keyword>
</DOC>